Lexicon Pharmaceuticals, Inc. Provides Clinical Pipeline Update and Reports 2012 Fourth Quarter and Full Year Financial Results

Published: Feb 21, 2013

The Woodlands, Texas, February 21, 2013 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2012.

Back to news